These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 23528342)

  • 1. Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid.
    Correa-Ruiz A; Girón R; Buendía B; Medina-Pascual MJ; Valenzuela C; López-Brea M; Sáez-Nieto JA
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):649-54. PubMed ID: 23528342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal diversity among Burkholderia cepacia complex isolates from cystic fibrosis patients in a reference unit.
    Barrado L; Martinez MT; Villa J; Orellana MÁ; Viedma E; Chaves F
    Enferm Infecc Microbiol Clin; 2013 Dec; 31(10):665-8. PubMed ID: 23850187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.
    Medina-Pascual MJ; Valdezate S; Villalón P; Garrido N; Rubio V; Saéz-Nieto JA
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3385-96. PubMed ID: 22855365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
    Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
    Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis.
    Jones AM; Dodd ME; Govan JR; Barcus V; Doherty CJ; Morris J; Webb AK
    Thorax; 2004 Nov; 59(11):948-51. PubMed ID: 15516469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Characterization of genotypes for Burkholderia cepacia complex strains isolated from patients in hospitals of Russian Federation].
    Voronina AL; Chernukha MY; Shaginyan IA; Kunda MS; Avetisyan LR; Orlova AA; Lunin VG; Avakyan LV; Kapranov NI; Amelina EL; Chuchalin AG; Gintsburg A L
    Mol Gen Mikrobiol Virusol; 2013; (2):22-30. PubMed ID: 24003509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonality and Antimicrobial Susceptibility of Burkholderia cepacia complex Isolates Collected from Cystic Fibrosis Patients during 1998-2013 in Bern, Switzerland.
    Lupo A; Isis E; Tinguely R; Endimiani A
    New Microbiol; 2015 Apr; 38(2):281-8. PubMed ID: 25938755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres.
    Boussaud V; Guillemain R; Grenet D; Coley N; Souilamas R; Bonnette P; Stern M
    Thorax; 2008 Aug; 63(8):732-7. PubMed ID: 18408050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.
    Dentini P; Marson FAL; Bonadia LC; Bertuzzo CS; Ribeiro AF; Levy CE; Ribeiro JD
    Med Microbiol Immunol; 2017 Dec; 206(6):447-461. PubMed ID: 28965239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children.
    Power RF; Linnane B; Martin R; Power N; Harnett P; Casserly B; O'Connell NH; Dunne CP
    BMC Pulm Med; 2016 Apr; 16(1):57. PubMed ID: 27103163
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Hassan AA; Coutinho CP; Sá-Correia I
    Front Cell Infect Microbiol; 2019; 9():273. PubMed ID: 31417878
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.
    Coutinho CP; Dos Santos SC; Madeira A; Mira NP; Moreira AS; Sá-Correia I
    Front Cell Infect Microbiol; 2011; 1():12. PubMed ID: 22919578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Switching Partners": Piperacillin-Avibactam Is a Highly Potent Combination against Multidrug-Resistant
    Zeiser ET; Becka SA; Wilson BM; Barnes MD; LiPuma JJ; Papp-Wallace KM
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burkholderia cepacia complex infection in a cohort of Italian patients with cystic fibrosis.
    Lambiase A; Raia V; Stefani S; Sepe A; Ferri P; Buonpensiero P; Rossano F; Del Pezzo M
    J Microbiol; 2007 Jun; 45(3):275-9. PubMed ID: 17618236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
    Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
    J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical course of Burkholderia cepacia complex bacteria respiratory infection in cystic fibrosis patients.
    Correia S; Nascimento C; Pereira L; Cunha MV; Sá-Correia I; Barreto C
    Rev Port Pneumol; 2008; 14(1):5-26. PubMed ID: 18265915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.